• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 22

Substance: alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding a modified alpha-amylase derived from Bacillus lichenformis and Bacillus amyloliquefaciens
Intended Use: Use in the starch industry (for the liquefaction of starch in the production of syrups), and in the alcohol industry (for the thinning of starch in distilling mashes) as a processing aid at minimum levels necessary to accomplish the intended technical effect in accordance with current good manufacturing practices
Basis: Scientific procedures
Notifier: Novo Nordisk
77 Perry Chapel Church Rd., Box 576; Franklinton, NC 27525
Date of filing: May 24, 1999
GRAS Notice (releasable information): 22
Date of closure / FDA's Letter: Dec 29, 1999
FDA has no questions
-
-